01177 中國生物製藥
公司資料 - 財務狀況表
中國生物製藥有限公司 股票編號: 01177
SINO BIOPHARMACEUTICAL LTD. 集團網址: http://www.sinobiopharm.com
非流動資產
2024/12 - 末期
人民幣(K¥)
與去年末期
比較
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
投資物業269,030-7.020%289,342720,754705,626308,559
物業、廠房、設備及其他8,691,3827.555%8,080,9077,759,5927,154,2986,870,288
租賃土地1,596,774-12.804%1,831,2541,491,5911,361,7641,521,916
無形資產3,060,9665.225%2,908,9611,914,4501,711,9461,013,636
聯營公司及共同控制公司權益1,620,085-86.768%12,243,67513,198,15714,266,3965,050,637
其他非流動資產25,484,50176.423%14,445,14913,044,83511,840,1299,651,199
40,722,7382.320%39,799,28838,129,37937,040,15924,416,235
存貨2,373,14519.046%1,993,4722,328,8441,937,7411,880,051
 
流動資產
現金及銀行結存9,569,5841.245%9,451,87812,066,21710,568,81211,259,084
其他流動資產12,742,60211.314%11,447,47511,539,84410,996,6259,655,068
持作出售資產0--912,706000
24,685,3313.696%23,805,53125,934,90523,503,17822,794,203
 
流動負債
其他流動負債19,556,490-12.569%22,367,91620,150,67715,345,01910,943,539
持作出售資產相關負債0--238,859000
19,556,490-13.493%22,606,77520,150,67715,345,01910,943,539
流動資產淨值5,128,841327.847%1,198,7565,784,2288,158,15911,850,664
資產總額減流動負債45,851,57911.838%40,998,04443,913,60745,198,31836,266,899
 
非流動負債
3,077,5098.819%2,828,0915,970,0597,469,29513,847,341
 
資本及儲備
   股本414,384-0.056%414,615414,899415,440415,895
   儲備31,546,4054.945%30,059,85429,332,13629,875,67616,331,265
   其他0--0000
股東資金31,960,7894.877%30,474,46929,747,03530,291,11616,747,160
非控股權益10,813,28140.515%7,695,4848,196,5137,437,9075,672,398
其他0--0000
42,774,07012.062%38,169,95337,943,54837,729,02322,419,558
 
承擔及或然負債
承擔----535,5461,811,239950,0381,224,839
或然負債----0000
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.